Cutler Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Cutler Group’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-400	Closed	-$1K	–	5460
2017 Q4	$1K	Buy	+400	New	+$7.25K	﹤0.01%	4659

Other funds holding SPPI

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cutler Group's SPPI Position: Q3 2020 in Review

Cutler Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2020, closing a stake of 200 shares.

Cutler Group first reported a position in SPPI in Q1 2017 and held it in 7 quarters. The position peaked at $58K in Q4 2017. 159 funds tracked by Wall St. Rank hold SPPI as of Q3 2020.

Cutler Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
Cutler Group sold 200 Spectrum Pharmaceuticals Inc shares in Q3 2020.
Cutler Group first reported a position in Spectrum Pharmaceuticals Inc in Q1 2017 and held it in 7 quarters.
Cutler Group's Spectrum Pharmaceuticals Inc position peaked at $58K in Q4 2017.
159 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2020.

Based on Cutler Group's 13F filing for Q3 2020, filed 27 Oct 2020.